Source: HealthDay News
Date: November 27, 2006
Summary:
A new study by researchers from the University of British Columbia and the BC Cancer Agency. has found that Patients with diseases such as leukemia or myelodysplastic syndrome who receive a hematopoietic stem cell transplant (HSCT) have an increased long-term risk of developing a cancer.
No comments:
Post a Comment